APA (7th ed.) Citation

Sutherland, M., Gill, J. H., Loadman, P. M., Laye, J. P., Sheldrake, H. M., Illingworth, N. A., . . . Patterson, L. H. (2013). Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder. Molecular cancer therapeutics, 12(1), 27-37. https://doi.org/10.1158/1535-7163.MCT-12-0405

Chicago Style (17th ed.) Citation

Sutherland, Mark, et al. "Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder." Molecular Cancer Therapeutics 12, no. 1 (2013): 27-37. https://doi.org/10.1158/1535-7163.MCT-12-0405.

MLA (9th ed.) Citation

Sutherland, Mark, et al. "Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder." Molecular Cancer Therapeutics, vol. 12, no. 1, 2013, pp. 27-37, https://doi.org/10.1158/1535-7163.MCT-12-0405.